Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Ultrasound
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula."
- "EBUS is a technique that uses ultrasound along with bronchoscopy to visualize the airway wall and structures adjacent to it."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares high-flow oxygen through small tubes in the nose with regular oxygen tubes during EBUS bronchoscopy, a test that uses a scope and ultrasound to look inside the airways. It checks whether high-flow oxygen leads to fewer pauses, fewer and shorter drops in oxygen levels, and a shorter test. It is for adults over 18 who receive medicine to relax them during the test.
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are older than 18.
- You are having EBUS bronchoscopy with moderate conscious sedation, medicine that relaxes you while you stay awake.
Who can't join
- You have had nose surgery.
- Your blood oxygen level is below 90% while breathing room air before the test.
- You are pregnant.
- You have known broken bones in your face or a recent face injury.
- You take blood-thinning medicine that cannot be stopped before the test.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * age\>18 years * patient undergoing EBUS bronchoscopy with moderate conscious sedation. Exclusion Criteria: * subjects with previous nasal surgeries * subjects with oxygen saturation \<90% on room air prior to procedure * subjects who are pregnant * subjects with known facial fractures or recent facial trauma * subjects on any anticoagulation that cannot be discontinued prior to the procedure
Study sites (1)
NJ
- Cooper University Hospital · Camden, NJ 08103Wissam Abouzgheib, MD · Study contact · 800-826-6737 · abouzgheib-wissam@cooperhealth.eduChristopher Ambrogi, DO · Study contact · ambrogi-christopher@cooperhealth.eduWissam Abouzgheib, MD · Principal investigatorMore trials in Camden